[The 43rd Report on the Survey of Adverse Reactions to Radiopharmaceuticals (46th Survey in 2020)].


Journal

Kaku igaku. The Japanese journal of nuclear medicine
ISSN: 2189-9932
Titre abrégé: Kaku Igaku
Pays: Japan
ID NLM: 2985202R

Informations de publication

Date de publication:
2022
Historique:
entrez: 24 3 2022
pubmed: 25 3 2022
medline: 26 3 2022
Statut: ppublish

Résumé

This survey was performed to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2020 in Japan. The results are based on responses to questionnaires sent to nuclear medicine centers. Replies were obtained from 1,006 centers out of 1,212 to which the questionnaire was sent. A total of 940,758 administrations of radiopharmaceuticals were reported. There were 17 cases with adverse reactions, giving an incidence of adverse reactions of 1.8 per 100,000 cases. Two cases of defective products were reported, giving an incidence of defective products of 0.2 per 100,000 cases.

Identifiants

pubmed: 35321966
doi: 10.18893/kakuigaku.rp.2231
doi:

Substances chimiques

Radiopharmaceuticals 0

Types de publication

Journal Article

Langues

jpn

Sous-ensembles de citation

IM

Pagination

1-12

Auteurs

Hidehiko Okazawa (H)

Biomedical Imaging Research Center, University of Fukui.

Tomoya Uehara (T)

Graduate School of Pharmaceutical Sciences, Chiba University.

Ichiei Kuji (I)

Department of Nuclear Medicine, Saitama Medical University International Medical Center.

Tatsuya Higashi (T)

Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology.

Mana Yoshimura (M)

Department of Radiology, Tokyo Medical University.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
1.00
Humans Female Sick Leave Norway Sinusitis
Humans Mobile Applications Hepatitis C Male Female
Humans Male Female Health Knowledge, Attitudes, Practice Middle Aged

Classifications MeSH